This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
19. In schedule 4 (information to be included in applications for consent to market genetically modified organisms), in Part 1 (general information)—
(a)for paragraph 1, substitute—
“1. The proposed commercial name of the product or products (which must be provided to the competent authority after consent has been granted) and name or names of the genetically modified organism or organisms in the product or products, and a proposal for a unique identifier of the genetically modified organism developed in accordance with Commission Regulation (EC) No 65/2004 establishing a system for the development and assignment of unique identifiers for genetically modified organisms(1).”, and
(b)for paragraph 7, substitute—
“7. Methods for the detection, identification and, where appropriate, quantification of the transformation event, samples of the genetically modified organism or organisms and their control samples, and information as to the place where the reference material can be accessed (identifying any such information that cannot be placed, for confidentiality reasons, in the publicly accessible part of the register referred to in Article 31(2) of the Deliberate Release Directive).”.
OJ L 10, 16.01.2004, p.5.
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
